E.Zimmermann-KogadeevaM.PatilK
1 Approved under the brand name Zepbound in the U.S
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 18 Appendicitis After Initiation of Tirzepatide Authors Chan G , Ansar M, Klein M Received 9 October 2024 Accepted for publication 15 January 2025 Published 31 January 2025 Volume 2025:18 Pages 261265 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Garrett Chan 1 , Mariam Ansar 1 , Marlena Klein 1,2 1 Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA
If you are on higher doses above 1.0mg and want to minimize injection volume, 1.0 mL works but demands very careful measurement
Slim Transformation Oct 9, 2025 4 min read No Wegovy is for subcutaneous use only